Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06549595
PHASE3

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

Sponsor: AstraZeneca

View on ClinicalTrials.gov

Summary

This is a global, randomised, Phase III, multicentre, open-label study evaluating the efficacy, safety and the degree of added benefit of the Surovatamig (AZD0486) plus rituximab combination compared to Investigator's choice of 3 standard immunochemotherapy regimen, conducted in participants with untreated FL.

Official title: A Phase III, Multicentre, Randomised, Open-label Study to Compare the Efficacy and Safety of AZD0486 Plus Rituximab Versus Chemotherapy Plus Rituximab in Previously Untreated Participants With Follicular Lymphoma (SOUNDTRACK-F1)

Key Details

Gender

All

Age Range

18 Years - 130 Years

Study Type

INTERVENTIONAL

Enrollment

1018

Start Date

2024-08-07

Completion Date

2031-11-26

Last Updated

2026-10-21

Healthy Volunteers

No

Interventions

DRUG

Surovatamig

a fully human bispecific monoclonal IgG4 antibody

DRUG

R-CHOP

Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone

DRUG

R-CVP

Rituximab, Cyclophosphamide, Vincristine and Prednisone

DRUG

BR

Bendamustine, Rituximab

Locations (244)

Research Site

Huntsville, Alabama, United States

Research Site

Anchorage, Alaska, United States

Research Site

Phoenix, Arizona, United States

Research Site

Clovis, California, United States

Research Site

Los Alamitos, California, United States

Research Site

San Diego, California, United States

Research Site

Santa Monica, California, United States

Research Site

Aurora, Colorado, United States

Research Site

New Haven, Connecticut, United States

Research Site

Newark, Delaware, United States

Research Site

Jacksonville, Florida, United States

Research Site

Atlanta, Georgia, United States

Research Site

Macon, Georgia, United States

Research Site

Evanston, Illinois, United States

Research Site

Peoria, Illinois, United States

Research Site

Fort Wayne, Indiana, United States

Research Site

Des Moines, Iowa, United States

Research Site

Iowa City, Iowa, United States

Research Site

Lexington, Kentucky, United States

Research Site

Louisville, Kentucky, United States

Research Site

Baton Rouge, Louisiana, United States

Research Site

Baltimore, Maryland, United States

Research Site

Bethesda, Maryland, United States

Research Site

Columbia, Maryland, United States

Research Site

Boston, Massachusetts, United States

Research Site

Boston, Massachusetts, United States

Research Site

Ann Arbor, Michigan, United States

Research Site

Detroit, Michigan, United States

Research Site

Ypsilanti, Michigan, United States

Research Site

Rochester, Minnesota, United States

Research Site

Saint Paul, Minnesota, United States

Research Site

Chesterfield, Missouri, United States

Research Site

Springfield, Missouri, United States

Research Site

Hackensack, New Jersey, United States

Research Site

New Brunswick, New Jersey, United States

Research Site

Albany, New York, United States

Research Site

Brooklyn, New York, United States

Research Site

Mineola, New York, United States

Research Site

New Hyde Park, New York, United States

Research Site

New York, New York, United States

Research Site

New York, New York, United States

Research Site

New York, New York, United States

Research Site

Charlotte, North Carolina, United States

Research Site

Charlotte, North Carolina, United States

Research Site

Wilmington, North Carolina, United States

Research Site

Winston-Salem, North Carolina, United States

Research Site

Blue Ash, Ohio, United States

Research Site

Cincinnati, Ohio, United States

Research Site

Columbus, Ohio, United States

Research Site

Eugene, Oregon, United States

Research Site

Portland, Oregon, United States

Research Site

Pittsburgh, Pennsylvania, United States

Research Site

Nashville, Tennessee, United States

Research Site

Austin, Texas, United States

Research Site

Lubbock, Texas, United States

Research Site

Shenandoah, Texas, United States

Research Site

Tyler, Texas, United States

Research Site

Salt Lake City, Utah, United States

Research Site

Fairfax, Virginia, United States

Research Site

Richmond, Virginia, United States

Research Site

Tacoma, Washington, United States

Research Site

Madison, Wisconsin, United States

Research Site

Milwaukee, Wisconsin, United States

Research Site

Clayton, Australia

Research Site

Darlinghurst, Australia

Research Site

Garran, Australia

Research Site

Heidelberg, Australia

Research Site

Macquarie University, Australia

Research Site

Nedlands, Australia

Research Site

Brussels, Belgium

Research Site

Brussels, Belgium

Research Site

Ghent, Belgium

Research Site

Mechelen, Belgium

Research Site

Porto Alegre, Brazil

Research Site

São Paulo, Brazil

Research Site

São Paulo, Brazil

Research Site

Winnipeg, Manitoba, Canada

Research Site

Halifax, Nova Scotia, Canada

Research Site

Barrie, Ontario, Canada

Research Site

Hamilton, Ontario, Canada

Research Site

Oshawa, Ontario, Canada

Research Site

Toronto, Ontario, Canada

Research Site

Chicoutimi, Quebec, Canada

Research Site

Montreal, Quebec, Canada

Research Site

Québec, Quebec, Canada

Research Site

Saint-Jérôme, Quebec, Canada

Research Site

Beijing, China

Research Site

Beijing, China

Research Site

Beijing, China

Research Site

Changchun, China

Research Site

Changsha, China

Research Site

Chengdu, China

Research Site

Chongqing, China

Research Site

Fuzhou, China

Research Site

Guangzhou, China

Research Site

Guangzhou, China

Research Site

Guangzhou, China

Research Site

Hangzhou, China

Research Site

Hangzhou, China

Research Site

Harbin, China

And 144 more locations on ClinicalTrials.gov